Who are BMRN institutional owners?

View hedge funds, mutual funds, and asset managers that own Biomarin Pharmaceutical Inc. shares as reported in quarterly 13F filings.

What percentage of BMRN is held by institutions?

Biomarin Pharmaceutical Inc. institutional ownership percentage indicates how much of the company is owned by professional investors.

Compare quarter-over-quarter changes in Biomarin Pharmaceutical Inc. institutional holdings to identify accumulation or distribution patterns.

13F filings are quarterly SEC reports where institutional investors with over $100M disclose their holdings including Biomarin Pharmaceutical Inc..

Data table placeholder - wire to API in batch 12

Who are BMRN institutional owners?: View hedge funds, mutual funds, and asset managers that own Biomarin Pharmaceutical Inc. shares as reported in quarterly 13F filings.
What percentage of BMRN is held by institutions?: Biomarin Pharmaceutical Inc. institutional ownership percentage indicates how much of the company is owned by professional investors.
Are institutions buying BMRN?: Compare quarter-over-quarter changes in Biomarin Pharmaceutical Inc. institutional holdings to identify accumulation or distribution patterns.
What is a 13F filing?: 13F filings are quarterly SEC reports where institutional investors with over $100M disclose their holdings including Biomarin Pharmaceutical Inc..

Data table placeholder - wire to API in batch 12

Who are BMRN institutional owners?: View hedge funds, mutual funds, and asset managers that own Biomarin Pharmaceutical Inc. shares as reported in quarterly 13F filings.
What percentage of BMRN is held by institutions?: Biomarin Pharmaceutical Inc. institutional ownership percentage indicates how much of the company is owned by professional investors.
Are institutions buying BMRN?: Compare quarter-over-quarter changes in Biomarin Pharmaceutical Inc. institutional holdings to identify accumulation or distribution patterns.
What is a 13F filing?: 13F filings are quarterly SEC reports where institutional investors with over $100M disclose their holdings including Biomarin Pharmaceutical Inc..